Colour theme
Theme
Sign in
Insider · CIK 0001313516

Jorden David Emerson

CIK 0001313516 Name as filed on the most recent filing

Filed as Jorden David Emerson (111)

133 transaction lines · from 111 filings · filed 2008-10-01 to 2025-12-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

133 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-11-28 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 200,000 disposed 1.50 300,000.00 Form 4, filing 0001437749-25-036821
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 30,000 disposed 1.50 45,000.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 30,000 disposed 1.50 45,000.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 27,000 disposed 1.50 40,500.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 20,000 disposed 1.50 30,000.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 20,000 disposed 1.50 30,000.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 13,500 disposed 1.50 20,250.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 10,000 disposed 1.50 15,000.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 7,000 disposed 1.50 10,500.00 Form 4, filing 0001437749-22-027386
2022-11-09 Nuo Therapeutics, Inc.
AURX
S, Open-market sale 5,000 disposed 1.50 7,500.00 Form 4, filing 0001437749-22-027386
2017-08-10 Nuo Therapeutics, Inc.
AURX
P, Open-market purchase 247,500 acquired 0.22 54,994.50 Form 4, filing 0001674752-17-000002
2017-06-14 PLx Pharma Inc.
PLXP
P, Open-market purchase 32,727 acquired 6.88 224,998.12 Form 4, filing 0001313516-17-000001
2016-05-05 Nuo Therapeutics, Inc.
NONE
P, Open-market purchase 137,500 acquired 1.00 137,500.00 Form 4, filing 0001144204-16-115372
2013-05-21 Cytomedix Inc
CMXI
P, Open-market purchase 55,000 acquired 0.50 27,500.00 Form 4, filing 0001144204-13-030756
2013-05-17 Cytomedix Inc
CMXI
P, Open-market purchase 25,000 acquired 0.50 12,500.00 Form 4, filing 0001144204-13-030756
2013-04-19 Cytomedix Inc
CMXI
P, Open-market purchase 15,000 acquired 0.50 7,500.00 Form 4, filing 0001144204-13-022925
2013-04-18 Cytomedix Inc
CMXI
P, Open-market purchase 20,000 acquired 0.51 10,200.00 Form 4, filing 0001144204-13-022925
2013-04-17 Cytomedix Inc
CMXI
P, Open-market purchase 15,000 acquired 0.51 7,650.00 Form 4, filing 0001144204-13-022925
2013-04-09 Cytomedix Inc
CMXI
P, Open-market purchase 31,515 acquired 0.52 16,387.80 Form 4, filing 0001144204-13-020855
2013-04-08 Cytomedix Inc
CMXI
P, Open-market purchase 43,485 acquired 0.51 22,177.35 Form 4, filing 0001144204-13-020855
2013-02-27 Cytomedix Inc
CMXI
P, Open-market purchase 4,400 acquired 0.53 2,332.00 Form 4, filing 0001144204-13-011515
2013-02-26 Cytomedix Inc
CMXI
P, Open-market purchase 20,600 acquired 0.52 10,712.00 Form 4, filing 0001144204-13-011515
2013-02-22 Cytomedix Inc
CMXI
P, Open-market purchase 20,000 acquired 0.53 10,600.00 Form 4, filing 0001144204-13-010662
2013-02-21 Cytomedix Inc
CMXI
P, Open-market purchase 30,000 acquired 0.53 15,900.00 Form 4, filing 0001144204-13-010662
2012-09-14 Cytomedix Inc
CMXI
P, Open-market purchase 25,000 acquired 0.89 22,250.00 Form 4, filing 0001144204-12-051417
2012-09-11 Cytomedix Inc
CMXI
P, Open-market purchase 8,333 acquired 0.95 7,916.35 Form 4, filing 0001144204-12-050772
2012-02-15 Cytomedix Inc
CMXI
S, Open-market sale 76,313 disposed 1.15 88,065.20 Form 4, filing 0001144204-12-009382
2012-02-14 Cytomedix Inc
CMXI
S, Open-market sale 27,000 disposed 1.20 32,400.00 Form 4, filing 0001144204-12-009382
2012-02-13 Cytomedix Inc
CMXI
S, Open-market sale 39,775 disposed 1.25 49,798.30 Form 4, filing 0001144204-12-009382
2011-06-07 Cytomedix Inc
CMXI
P, Open-market purchase 22,500 acquired 0.34 7,740.00 Form 4, filing 0001144204-11-034443
2011-05-20 Cytomedix Inc
CMXI
P, Open-market purchase 15,000 acquired 0.38 5,625.00 Form 4, filing 0001144204-11-031510
2011-05-19 Cytomedix Inc
CMXI
P, Open-market purchase 22,500 acquired 0.39 8,865.00 Form 4, filing 0001144204-11-031281
2011-05-04 Cytomedix Inc
CMXI
P, Open-market purchase 17,500 acquired 0.36 6,300.00 Form 4, filing 0001144204-11-026217
2011-05-03 Cytomedix Inc
CMXI
P, Open-market purchase 18,000 acquired 0.34 6,210.00 Form 4, filing 0001144204-11-025885
2011-05-02 Cytomedix Inc
CMXI
P, Open-market purchase 33,666 acquired 0.36 12,119.76 Form 4, filing 0001144204-11-025894
2011-05-02 Cytomedix Inc
CMXI
P, Open-market purchase 33,666 acquired 0.36 12,119.76 Form 4, filing 0001144204-11-025719
2011-04-29 Cytomedix Inc
CMXI
P, Open-market purchase 218,334 acquired 0.33 72,050.22 Form 4, filing 0001144204-11-025894
2011-04-29 Cytomedix Inc
CMXI
P, Open-market purchase 218,334 acquired 0.33 72,050.22 Form 4, filing 0001144204-11-025719
2011-03-16 Cytomedix Inc
CMXI
P, Open-market purchase 27,500 acquired 0.38 10,367.50 Form 4, filing 0001144204-11-015249
2011-03-15 Cytomedix Inc
CMXI
P, Open-market purchase 12,500 acquired 0.40 4,937.50 Form 4, filing 0001144204-11-014943
2011-03-14 Cytomedix Inc
CMXI
P, Open-market purchase 35,000 acquired 0.39 13,755.00 Form 4, filing 0001144204-11-014727
2011-03-11 Cytomedix Inc
CMXI
P, Open-market purchase 35,000 acquired 0.40 14,000.00 Form 4, filing 0001144204-11-014457
2011-03-09 Cytomedix Inc
CMXI
P, Open-market purchase 72,200 acquired 0.40 29,168.80 Form 4, filing 0001144204-11-013894
2011-03-09 Center Bancorp Inc
CMXI
P, Open-market purchase 72,200 acquired 0.40 29,168.80 Form 4, filing 0001144204-11-013769
2011-03-08 Cytomedix Inc
CMXI
P, Open-market purchase 72,800 acquired 0.40 29,484.00 Form 4, filing 0001144204-11-013496
2011-02-17 Cytomedix Inc
CMXI
P, Open-market purchase 13,414 acquired 0.43 5,768.02 Form 4, filing 0001144204-11-009994
2011-02-17 Cytomedix Inc
CMXI
P, Open-market purchase 41,586 acquired 0.44 18,131.50 Form 4, filing 0001144204-11-009688
2011-02-15 Cytomedix Inc
CMXI
P, Open-market purchase 15,000 acquired 0.42 6,300.00 Form 4, filing 0001144204-11-009041
2011-02-14 Cytomedix Inc
CMXI
P, Open-market purchase 12,450 acquired 0.44 5,478.00 Form 4, filing 0001144204-11-008851
2011-02-11 Cytomedix Inc
CMXI
P, Open-market purchase 27,550 acquired 0.44 12,204.65 Form 4, filing 0001144204-11-007982

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 120
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. JORDEN DAVID EMERSON, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001313516

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.